Context

Context of Examining how covered entities utilize the 340B drug pricing program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017
Processing Feedback ...